Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuppusamy, P.
Right arrow Articles by Mitchell, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuppusamy, P.
Right arrow Articles by Mitchell, J. B.
[Cancer Research 62, 307-312, January 1, 2002]
© 2002 American Association for Cancer Research


Tumor Biology

Noninvasive Imaging of Tumor Redox Status and Its Modification by Tissue Glutathione Levels1

Periannan Kuppusamy2, Haiquan Li, Govindasamy Ilangovan, Arturo J. Cardounel, Jay L. Zweier, Kenichi Yamada, Murali C. Krishna and James B. Mitchell

The EPR Center and Division of Cardiology, Department of Medicine, Johns Hopkins University, School of Medicine, Baltimore, Maryland 21224 [P. K., H. L., G. I., A. J. C., J. L. Z.], and Radiation Biology Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892 [K. Y., M. C. K., J. B. M.]

Therapeutic regimens such as radiation or chemotherapy attempt to exploit the physiological differences between normal and malignant tissue. Tissue redox status and pO2 are two factors that are hypothesized to be different in normal and malignant tissues. Methods that can detect subtle differences in the above physiological parameters would greatly aid in devising appropriate treatment strategies. We have previously used in vivo electron paramagnetic resonance (EPR) spectroscopy and imaging techniques and shown that tumor tissues are highly reducing and hypoxic compared with normal tissues (P. Kuppusamy et al., Cancer Res., 58: 1562–1568, 1998). The purpose of the present study was to obtain spatially resolved redox data from normal and tumor tissues of radiation-induced fibrosarcoma (RIF-1) tumor-bearing mice and to examine the role of intracellular glutathione (GSH) on the tissue redox status. Experiments were performed using low-frequency (1.3 GHz) in vivo EPR spectroscopy and imaging techniques with a nitroxide redox probe. L-buthionine-S,R-sulfoximine (BSO), an inhibitor of GSH synthesis, was used to deplete tissue GSH levels. The results show the existence of significant heterogeneity of redox status in the tumor tissue compared with normal tissue. The tumor tissues show at least 4-fold higher concentrations of GSH levels compared with normal tissues in the tumor-bearing mice. Also BSO treatment showed a differential depletion of GSH and reducing equivalents in the tumor tissue. Thus, it appears that there is significant heterogeneity of tumor redox status and that manipulation of the tumor redox status may be important in tumor growth and therapy.




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
C. S. Wilcox and A. Pearlman
Chemistry and Antihypertensive Effects of Tempol and Other Nitroxides
Pharmacol. Rev., December 1, 2008; 60(4): 418 - 469.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Hyodo, K.-i. Matsumoto, A. Matsumoto, J. B. Mitchell, and M. C. Krishna
Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-sensitive contrast agents.
Cancer Res., October 15, 2006; 66(20): 9921 - 9928.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K.-i. Matsumoto, F. Hyodo, A. Matsumoto, A. P. Koretsky, A. L. Sowers, J. B. Mitchell, and M. C. Krishna
High-Resolution Mapping of Tumor Redox Status by Magnetic Resonance Imaging Using Nitroxides as Redox-Sensitive Contrast Agents
Clin. Cancer Res., April 15, 2006; 12(8): 2455 - 2462.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Utsumi, K.-i. Yamada, K. Ichikawa, K. Sakai, Y. Kinoshita, S. Matsumoto, and M. Nagai
Simultaneous molecular imaging of redox reactions monitored by Overhauser-enhanced MRI with 14N- and 15N-labeled nitroxyl radicals
PNAS, January 31, 2006; 103(5): 1463 - 1468.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Hirayama, S. Nagase, A. Ueda, T. Oteki, K. Takada, M. Obara, M. Inoue, K. Yoh, K. Hirayama, and A. Koyama
In vivo imaging of oxidative stress in ischemia-reperfusion renal injury using electron paramagnetic resonance
Am J Physiol Renal Physiol, March 1, 2005; 288(3): F597 - F603.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. B. Mitchell, K. Yamada, N. Devasahayam, J. A. Cook, S. Subramanian, and M. C. Krishna
Novel Functional Imaging for Tissue Oxygen Concentration and Redox Status
J. Nutr., November 1, 2004; 134(11): 3210S - 3210S.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K.-i. Matsumoto, M. C. Krishna, and J. B. Mitchell
Novel Pharmacokinetic Measurement Using Electron Paramagnetic Resonance Spectroscopy and Simulation of in Vivo Decay of Various Nitroxyl Spin Probes in Mouse Blood
J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1076 - 1083.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.